Evidence map›Paper›PMID 36327102›Full record

ArticleJournal of chemical information and modeling2022

DyScore: A Boosting Scoring Method with Dynamic Properties for Identifying True Binders and Nonbinders in Structure-Based Drug Discovery.

Yanjun Li, Daohong Zhou, Guangrong Zheng, Xiaolin Li, Dapeng Wu, Yaxia Yuan

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Apo2Mol: 3D Molecule Generation via Dynamic Pocket-Aware Diffusion Models.Proceedings of the ... AAAI Conference on Artificial Intelligence. AAAI Conference on Artificial Intelligence · 2026
    Article
  2. Decision Tree for Prediction of Binding Affinity.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yanjun LiNSF Center for Big Learning, University of Florida, Gainesville, Florida32611, United States.
Daohong ZhouDepartment of Pharmacodynamics, Univerity of Florida, Gainesville, Florida32611, United States.
Guangrong ZhengDepartment of Medicinal Chemistry, University of Florida, Gainesville, Florida32611, United States.ORCID 0000-0002-8106-6663
Xiaolin LiCognization Lab, Palo Alto, California94306, United States.
Dapeng WuNSF Center for Big Learning, University of Florida, Gainesville, Florida32611, United States.
Yaxia YuanDepartment of Pharmacodynamics, Univerity of Florida, Gainesville, Florida32611, United States.ORCID 0000-0001-7094-4419

Funding

Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancerR01CA242003 · NCI · UNIVERSITY OF FLORIDA · PI TREVINO, JOSE G., ZHENG, GUANGRONG · 2019 to 2023
$2.6M
Develop BCL-xL proteolysis targeting chimeras as safer and better senolyticsR01AG063801 · NIA · UNIVERSITY OF FLORIDA · PI ELISSEEFF, JENNIFER H, ZHENG, GUANGRONG · 2019 to 2023
$2.6M
NCI NIH HHS R01 CA242003NIA NIH HHS R01 AG063801
6 · The paper itself

Abstract

The accurate prediction of protein-ligand binding affinity is critical for the success of computer-aided drug discovery. However, the accuracy of current scoring functions is usually unsatisfactory due to their rough approximation or sometimes even omittance of many factors involved in protein-ligand binding. For instance, the intrinsic dynamics of the protein-ligand binding state is usually disregarded in scoring function because these rapid binding affinity prediction approaches are only based on a representative complex structure of the protein and ligand in the binding state. That is, the dynamic protein-ligand binding complex ensembles are simplified as a static snapshot in calculation. In this study, two novel features were proposed for characterizing the dynamic properties of protein-ligand binding based on the static structure of the complex, which is expected to be a valuable complement to the current scoring functions. The two features demonstrate the geometry-shape matching between a protein and a ligand as well as the dynamic stability of protein-ligand binding. We further combined these two novel features with several classical scoring functions to develop a binary classification model called DyScore that uses the Extreme Gradient Boosting algorithm to classify compound poses as binders or non-binders. We have found that DyScore achieves state-of-the-art performance in distinguishing active and decoy ligands on both enhanced DUD data set and external test sets with both proposed novel features showing significant contributions to the improved performance. Especially, DyScore exhibits superior performance on early recognition, a crucial requirement for success in virtual screening and

Indexed as

ProteinsResearch DesignDrug DiscoveryLigandsProtein BindingLigandsProteins

Identifiers

PMID36327102
PMCPMC9983328

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.